Abstract

IntroductionNeurodegenerative diseases were associated with a decrease in histone acetylase transferase (HAT) activity, resulting in relative over-deacetylation. Histone deacetylase (HDAC) inhibitors were suggested as potentially neuroprotective agents. The aim of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call